Abstract
Cysteine proteases are implicated in a variety of human physiological processes and also form an essential component of the life cycle of a number of pathogenic protozoa and viruses. The present review highlights the drug design approaches utilized to understand the mechanism of inhibition and discovery of inhibitors against protozoal cysteine protease, falcipain (a cysteine protease of P. falciparum which causes malaria), and viral cysteine protease, SARS-CoV Mpro (a cysteine protease of severe acute respiratory syndrome corona virus). The article describes rational approaches for the design of inhibitors and focuses on a variety of structure as well as ligand-based modeling strategies adopted for the discovery of the inhibitors. Also, the key features of ligand recognition against these targets are accentuated. Although no apparent similarities exist between viral and protozoal cysteine proteases discussed here, the goal is to provide examples of rational drug design approaches adopted to design inhibitors against these proteases. The current review would be of interest to scientists engaged in the development of drug design strategies to target the cysteine proteases present in mammals and other lower order organisms.
Keywords: Malaria, SARS, cysteine protease, falcipain, SARS 3CLpro or Mpro, knowledge-based drug design
Current Computer-Aided Drug Design
Title: Computational Approaches for the Discovery of Cysteine Protease Inhibitors Against Malaria and SARS
Volume: 6 Issue: 1
Author(s): Falgun Shah, Prasenjit Mukherjee, Prashant Desai and Mitchell Avery
Affiliation:
Keywords: Malaria, SARS, cysteine protease, falcipain, SARS 3CLpro or Mpro, knowledge-based drug design
Abstract: Cysteine proteases are implicated in a variety of human physiological processes and also form an essential component of the life cycle of a number of pathogenic protozoa and viruses. The present review highlights the drug design approaches utilized to understand the mechanism of inhibition and discovery of inhibitors against protozoal cysteine protease, falcipain (a cysteine protease of P. falciparum which causes malaria), and viral cysteine protease, SARS-CoV Mpro (a cysteine protease of severe acute respiratory syndrome corona virus). The article describes rational approaches for the design of inhibitors and focuses on a variety of structure as well as ligand-based modeling strategies adopted for the discovery of the inhibitors. Also, the key features of ligand recognition against these targets are accentuated. Although no apparent similarities exist between viral and protozoal cysteine proteases discussed here, the goal is to provide examples of rational drug design approaches adopted to design inhibitors against these proteases. The current review would be of interest to scientists engaged in the development of drug design strategies to target the cysteine proteases present in mammals and other lower order organisms.
Export Options
About this article
Cite this article as:
Shah Falgun, Mukherjee Prasenjit, Desai Prashant and Avery Mitchell, Computational Approaches for the Discovery of Cysteine Protease Inhibitors Against Malaria and SARS, Current Computer-Aided Drug Design 2010; 6 (1) . https://dx.doi.org/10.2174/157340910790980142
DOI https://dx.doi.org/10.2174/157340910790980142 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation
Current Topics in Medicinal Chemistry An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever
Combinatorial Chemistry & High Throughput Screening 5-HT1A Receptor, an Old Target for New Therapeutic Agents
Current Topics in Medicinal Chemistry Subject Index To Volume 6
Anti-Cancer Agents in Medicinal Chemistry Phenolic Acids - Versatile Natural Moiety with Numerous Biological Applications
Current Topics in Medicinal Chemistry A Review of the Management of Lymphangiomas
Current Pediatric Reviews Preface
Current Bioactive Compounds A Deep Neural Network to Distinguish COVID-19 from other Chest Diseases Using X-ray Images
Current Medical Imaging Sialic Acid and the Central Nervous System: Perspectives on Biological Functions, Detection, Imaging Methods and Manipulation
CNS & Neurological Disorders - Drug Targets Longevity Pathways: HSF1 and FoxO Pathways, a New Therapeutic Target to Prevent Age-Related Diseases
Current Aging Science Elucidating the Genetic Factors Contributing Towards Susceptibility and Severity of Covid 19
Current Chinese Science Docking and PLS Studies on a Set of Thiophenes RNA Polymerase Inhibitors Against Staphylococcus aureus
Current Topics in Medicinal Chemistry Regulation of Granulocyte Apoptosis by Hemopoietic Growth Factors, Cytokines and Drugs: Potential Relevance to Allergic Inflammation
Current Drug Targets - Inflammation & Allergy The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Predicting the Metabolic Pathways of Small Molecules Based on Their Physicochemical Properties
Protein & Peptide Letters Synthesis of 3,4-Dihydropyrano[c]chromenes Using Carbon Microsphere Supported Copper Nanoparticles (Cu-NP/C) Prepared from Loaded Cation Exchange Resin as a Catalyst
Current Organic Synthesis Recent Patents and Advances on Nanotechnologies against Coronavirus
Recent Patents on Nanotechnology Carbohydrate Mimics and Lectins: A Source of New Drugs and Therapeutic Opportunities
Mini-Reviews in Medicinal Chemistry Recent Advances in the Development of 14-Alkoxy Substituted Morphinans as Potent and Safer Opioid Analgesics
Current Medicinal Chemistry Impact of COVID-19 Lockdown on Lethality of Suicide Cases
Current Psychiatry Research and Reviews